IL101860D0 - Heterocyclic derivatives - Google Patents

Heterocyclic derivatives

Info

Publication number
IL101860D0
IL101860D0 IL10186092A IL10186092A IL101860D0 IL 101860 D0 IL101860 D0 IL 101860D0 IL 10186092 A IL10186092 A IL 10186092A IL 10186092 A IL10186092 A IL 10186092A IL 101860 D0 IL101860 D0 IL 101860D0
Authority
IL
Israel
Prior art keywords
heterocyclic derivatives
heterocyclic
derivatives
Prior art date
Application number
IL10186092A
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB919111759A priority Critical patent/GB9111759D0/en
Priority to GB919116309A priority patent/GB9116309D0/en
Application filed by Ici Plc filed Critical Ici Plc
Publication of IL101860D0 publication Critical patent/IL101860D0/en

Links

IL10186092A 1991-05-31 1992-05-14 Heterocyclic derivatives IL101860D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB919111759A GB9111759D0 (en) 1991-05-31 1991-05-31 Heterocyclic compounds
GB919116309A GB9116309D0 (en) 1991-07-29 1991-07-29 Bicyclic derivatives

Publications (1)

Publication Number Publication Date
IL101860D0 true IL101860D0 (en) 1992-12-30

Family

ID=26298984

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10186092A IL101860D0 (en) 1991-05-31 1992-05-14 Heterocyclic derivatives

Country Status (22)

Country Link
US (2) US5217976A (en)
EP (1) EP0516392B1 (en)
JP (1) JPH05163271A (en)
KR (1) KR920021545A (en)
CN (1) CN1073174A (en)
AP (1) AP9200388A0 (en)
AT (1) AT204873T (en)
AU (1) AU1625192A (en)
CA (1) CA2068946A1 (en)
CS (1) CS161892A3 (en)
DE (1) DE69232022D1 (en)
FI (1) FI922481A (en)
GB (1) GB2256196B (en)
HU (1) HUT61303A (en)
IE (1) IE921506A1 (en)
IL (1) IL101860D0 (en)
NO (1) NO922147L (en)
OA (1) OA9982A (en)
PL (1) PL294736A1 (en)
SI (1) SI9200095A (en)
TW (1) TW213914B (en)
YU (1) YU56192A (en)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9208116D0 (en) 1992-04-13 1992-05-27 Ici Plc Therapeutic agents
DE69325574T2 (en) * 1992-04-13 2000-03-16 Zeneca Ltd ANGIOTENSIN II ANTAGONISTS AGAINST DISORDERS; WITH A limited; NEURAL LINE SPEED CONNECTION WITH PARTICULAR diabetic neuropathy
GB9211270D0 (en) * 1992-05-28 1992-07-15 Ici Plc Nitrogen compounds
US5466692A (en) * 1993-03-24 1995-11-14 American Home Products Corporation Substituted pyridopyrimidines and antihypertensives
AT175413T (en) * 1993-03-24 1999-01-15 American Home Prod Substituted pyridopyrimidines as antihypertensives
US5468867A (en) * 1994-05-27 1995-11-21 Syntex (U.S.A.) Inc. Process for preparing1-butyl-2-[2'-(2H-tetrazol-5-yl)biphenyl-4-ylmethyl1-1H-indole-3-carboxylic acid
US5412102A (en) * 1994-05-27 1995-05-02 Syntex (U.S.A.) Inc. Processes for preparing 1-butyl-2-[2'-(2H-tetrazol-5-yl) biphenyl-4-ylmethyl]-1H-indole-3-carboxylic acid
US5801183A (en) * 1995-01-27 1998-09-01 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Aza and aza (N-oxy) analogs of glycine/NMDA receptor antagonists
TW486479B (en) * 1997-07-15 2002-05-11 Dainippon Pharmaceutical Co 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1H)-one derivatives
SE9903028D0 (en) 1999-08-27 1999-08-27 Astra Ab New use
ES2274913T3 (en) * 2000-10-12 2007-06-01 MERCK & CO., INC. Aza and polyaza-naphthalenyl carboxamides useful as inhibitors of HIV integrated.
EP1326611B1 (en) * 2000-10-12 2007-06-13 Merck & Co., Inc. Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors
WO2002030931A2 (en) 2000-10-12 2002-04-18 Merck & Co., Inc. Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
AR036256A1 (en) * 2001-08-17 2004-08-25 Merck & Co Inc sodium salt of an inhibitor of HIV integrase, processes for their preparation, pharmaceutical compositions containing them and their use for the manufacture of a medicament
WO2003027113A1 (en) 2001-09-26 2003-04-03 Bayer Pharmaceuticals Corporation 1,6-naphthyridine derivatives as antidiabetics
AT370948T (en) * 2002-01-17 2007-09-15 Merck & Co Inc Hydroxynaphthyridinoncarbonsäureamide which are suitable as inhibitors of HIV-integrase
EP1496836B1 (en) * 2002-03-15 2008-09-24 Merck & Co., Inc. N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors
JP4828822B2 (en) * 2002-05-24 2011-11-30 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. CCR9 inhibitors and methods of use thereof
AU2003252259A1 (en) * 2002-07-26 2004-02-16 Nihon Nohyaku Co., Ltd. Novel haloalkylsulfonanilide derivatives, herbicides and usage thereof
JP2004107323A (en) * 2002-07-26 2004-04-08 Nippon Nohyaku Co Ltd New haloalkylsulfone anilide derivative, herbicide and use thereof
EP1539714B1 (en) * 2002-09-11 2008-08-13 Merck & Co., Inc. 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors
US7517532B2 (en) * 2002-09-11 2009-04-14 Merck & Co., Inc. Dihydroxypyridopyrazine-1,6-dione compounds useful as HIV integrase inhibitors
CA2536967A1 (en) * 2003-08-28 2005-03-17 Nitromed, Inc. Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
EP1677599A4 (en) * 2003-10-20 2008-10-22 Merck & Co Inc Hydroxy pyridopyrrolopyrazine dione compounds useful as hiv integrase inhibitors
DK2170930T3 (en) 2007-06-04 2012-11-05 Synergy Pharmaceuticals Inc Agonists of guanylate cyclase, useful for the treatment of gastrointestinal disorders, inflammation, cancer and other diseases
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US8034782B2 (en) 2008-07-16 2011-10-11 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010083444A1 (en) * 2009-01-15 2010-07-22 Anvyl, Llc Alpha7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof
MY162507A (en) 2009-06-29 2017-06-15 Incyte Holdings Corp Pyrimidinones as pi3k inhibitors
WO2011031745A1 (en) 2009-09-09 2011-03-17 Achaogen, Inc. Antibacterial fluoroquinolone analogs
WO2011075643A1 (en) 2009-12-18 2011-06-23 Incyte Corporation Substituted heteroaryl fused derivatives as pi3k inhibitors
TW201130842A (en) * 2009-12-18 2011-09-16 Incyte Corp Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors
WO2011130342A1 (en) 2010-04-14 2011-10-20 Incyte Corporation FUSED DERIVATIVES AS ΡI3Κδ INHIBITORS
RU2438672C1 (en) * 2010-04-30 2012-01-10 Общество с ограниченной ответственностью "Клевер Фарм" Agent showing properties of cognitive function activator (versions)
US9062055B2 (en) 2010-06-21 2015-06-23 Incyte Corporation Fused pyrrole derivatives as PI3K inhibitors
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9096600B2 (en) 2010-12-20 2015-08-04 Incyte Corporation N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
US9108984B2 (en) 2011-03-14 2015-08-18 Incyte Corporation Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
WO2012135009A1 (en) 2011-03-25 2012-10-04 Incyte Corporation Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
DK3196202T3 (en) 2011-09-02 2019-05-13 Incyte Holdings Corp Heterocyclylamins as pi3k inhibitors
JP6014155B2 (en) 2011-10-31 2016-10-25 ゼノン・ファーマシューティカルズ・インコーポレイテッドXenon Pharmaceuticals Inc. Biaryl ether sulfonamides and their use as therapeutic agents
KR20140091022A (en) 2011-10-31 2014-07-18 제논 파마슈티칼스 인크. Benzenesulfonamide compounds and their use as therapeutic agents
AR090548A1 (en) 2012-04-02 2014-11-19 Incyte Corp Azaheterociclobencilaminas bicyclic inhibitors of PI3K
JP6038297B2 (en) * 2012-05-22 2016-12-07 ジェネンテック, インコーポレイテッド N-substituted benzamides and their use in the treatment of pain
EP2867215B1 (en) * 2012-06-25 2018-07-18 Saniona A/S Tetrazole derivatives and their use as potassium channel modulators
JP6309519B2 (en) 2012-07-06 2018-04-11 ジェネンテック, インコーポレイテッド N-substituted benzamide and method of using the same
CA2898679A1 (en) 2013-03-14 2014-09-25 Xenon Pharmaceuticals Inc. Substituted triazolopyridines and methods of use thereof
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP6227112B2 (en) 2013-03-15 2017-11-08 ジェネンテック, インコーポレイテッド Substituted benzoxazole and methods of use
JP2016522216A (en) 2013-06-05 2016-07-28 シナジー ファーマシューティカルズ インコーポレイテッド Ultra high purity agonist of guanylate cyclase C, method for producing and using the same
CN104418853B (en) * 2013-08-28 2016-09-07 北大方正集团有限公司 Substituted naphthalene-2-one compound, preparation, use and pharmaceutical compositions
PE12472016A1 (en) 2013-11-27 2016-11-30 Genentech Inc substituted benzamides and methods for use
WO2015112465A1 (en) * 2014-01-24 2015-07-30 Merck Sharp & Dohme Corp. Isoquinoline derivatives as mgat2 inhibitors
WO2015191677A1 (en) 2014-06-11 2015-12-17 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors
WO2016007534A1 (en) 2014-07-07 2016-01-14 Genentech, Inc. Therapeutic compounds and methods of use thereof
MX2017010918A (en) 2015-02-27 2018-05-04 Incyte Corp Salts of pi3k inhibitor and processes for their preparation.
US9988401B2 (en) 2015-05-11 2018-06-05 Incyte Corporation Crystalline forms of a PI3K inhibitor
WO2016183060A1 (en) 2015-05-11 2016-11-17 Incyte Corporation Process for the synthesis of a phosphoinositide 3-kinase inhibitor
JP2018520107A (en) 2015-05-22 2018-07-26 ジェネンテック, インコーポレイテッド Substituted benzamide and method of use

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920130A (en) * 1987-11-02 1990-04-24 Rorer Pharamceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4920132A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4920131A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
GT198900008A (en) * 1988-01-29 1990-07-17 Quinoline derivatives, quinazoline, and cinnoline.
IL89029A (en) * 1988-01-29 1993-01-31 Lilly Co Eli Fungicidal quinoline and cinnoline derivatives, compositions containing them, and fungicidal methods of using them
IE64514B1 (en) * 1989-05-23 1995-08-09 Zeneca Ltd Azaindenes
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc Di-substituted imidazo fused 6-membered nitrogen-containing heterocycles and pharmaceutical compositions containing them
CA2020073A1 (en) * 1989-07-03 1991-01-04 Eric E. Allen Substituted quinazolinones as angiotensin ii antagonists
EP0407342A3 (en) * 1989-07-06 1991-07-10 Ciba-Geigy Ag Pyrimidine derivatives
EP0412594B1 (en) * 1989-07-28 1996-01-03 Merck & Co., Inc. Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists
EP0412848B1 (en) * 1989-08-11 1995-01-18 Zeneca Limited Quinoline derivatives, process for their preparation and their use as medicaments
EP0424317A3 (en) * 1989-10-19 1991-09-25 Ciba-Geigy Ag Pyrimidines
IE903911A1 (en) * 1989-11-20 1991-05-22 Ici Plc Diazine derivatives
EP0435827A3 (en) * 1989-12-28 1991-11-13 Ciba-Geigy Ag Diaza compounds
WO1991009598A1 (en) * 1990-01-05 1991-07-11 Pfizer Inc. Azaoxindole derivatives
CA2037630C (en) * 1990-03-07 2001-07-03 Akira Morimoto Nitrogen-containing heterocylic compounds, their production and use
PT97078B (en) * 1990-03-20 1997-07-31 Sanofi Sa Process for the preparation of n-substituted heterocyclic derivatives and pharmaceutical compositions containing them
GB2244054B (en) * 1990-04-19 1994-04-06 Ici Plc Pyridine derivatives
KR100196559B1 (en) * 1990-06-19 1999-06-15 기따사또 이찌로 Pyridine derivatives with angiotensin ii antagonism
IE912956A1 (en) * 1990-09-10 1992-03-11 Abbott Lab Angiotensin ii receptor antagonists
IL100555A (en) * 1991-02-07 2000-08-31 Hoechst Marion Roussel Inc N-substituted quinoline derivatives their preparation their use for the preparation of medicaments and the pharmaceutical compositions containing them
IL100917D0 (en) * 1991-02-16 1992-11-15 Fisons Plc Pyridinone and pyrimidinone derivatives,their preparation and pharmaceutical compositions containing them
TW274551B (en) * 1991-04-16 1996-04-21 Takeda Pharm Industry Co Ltd
US5149699A (en) * 1991-10-24 1992-09-22 American Home Products Corporation Substituted pyridopyrimidines useful as antgiotensin II antagonists

Also Published As

Publication number Publication date
CN1073174A (en) 1993-06-16
DE69232022D1 (en) 2001-10-04
GB2256196A (en) 1992-12-02
CS161892A3 (en) 1992-12-16
NO922147L (en) 1992-12-01
AT204873T (en) 2001-09-15
KR920021545A (en) 1992-12-18
IE921506A1 (en) 1992-12-02
FI922481D0 (en)
EP0516392A2 (en) 1992-12-02
AP9200388A0 (en) 1992-07-31
HUT61303A (en) 1992-12-28
HU9201608D0 (en) 1992-08-28
YU56192A (en) 1994-11-15
US5217976A (en) 1993-06-08
EP0516392A3 (en) 1993-01-27
CA2068946A1 (en) 1992-12-01
OA9982A (en) 1996-03-29
FI922481A0 (en) 1992-05-29
PL294736A1 (en) 1993-05-31
JPH05163271A (en) 1993-06-29
FI922481A (en) 1992-12-01
SI9200095A (en) 1992-12-31
TW213914B (en) 1993-10-01
US5294620A (en) 1994-03-15
GB9211211D0 (en) 1992-07-08
EP0516392B1 (en) 2001-08-29
AU1625192A (en) 1992-12-03
GB2256196B (en) 1995-05-10
NO922147D0 (en) 1992-05-29

Similar Documents

Publication Publication Date Title
GB2255337B (en) Piperazine derivatives
ZA9203813B (en) Rapamycin derivatives
HU913052D0 (en) Heterocyclic compounds
HK1012363A1 (en) Substituted thiazolidinedione derivatives
GB2262093B (en) Piperazine derivatives
GB9207145D0 (en) Heterocyclic amides
HU913640D0 (en) 4-benzoyl-ixioazole derivatives
IE63047B1 (en) Heterocyclic derivatives
EP0440950A3 (en) Halogenallyl-azolyl derivatives
HU912356D0 (en) Rapacmycine derivatives
ZA9106098B (en) Oxazolidinodione derivatives
AU2280592A (en) New heterocyclic derivatives
LTIP491A (en) Hydroxyquinolone derivatives
ZA9400787B (en) New heterocyclic derivatives
IE903026A1 (en) Heterocyclic derivatives
HU9202267D0 (en) Pirazolo-pyrimidine derivatives
HU9204135D0 (en) Triazole-pyrimidine derivatives
IL102208D0 (en) Azanorbornane derivatives
GR3023621T3 (en) 3-Hydroxy-4-aryl-5-oxo-pyrazolin derivatives
IL103083D0 (en) Heterocyclic compounds
IE922420A1 (en) Heterocyclic compounds
HU9300486D0 (en) Hydroxi-urea derivatives
AU1625192A (en) Heterocyclic derivatives
IE914247A1 (en) Ó-Oxoacetamide Derivatives
IL109144D0 (en) Heterocyclic derivatives